NewCardio Study Shows CardioBip Detects Recurrent Atrial Fibrillation Earlier and More Reliably than Periodic Holter Monitoring(2)

Thu, 02/24/2011 - 3:36am

SANTA CLARA, Calif., Feb. 24, 2011 /PRNewswire/ -- PR Newswire – NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited by the Heart Rhythm Society (HRS) to present results of a recent clinical study showing that recurrent atrial fibrillation (AF) was accurately and timely detected in patients who used CardioBip™ for daily monitoring following catheter ablation procedures. The presentation, entitled "Long-term Intermittent Wireless Remote Monitoring of Reconstructed 12-Lead ECG in Post-Ablation AF Patients Using the CardioBip System", will be made at the 32nd Annual Scientific Sessions of the HRS, to be held in San Francisco, CA, May 4-7, 2011.

AF affects an estimated 1% of the worldwide population, with nearly three million AF patients in the US and six million AF patients in Europe. It is a serious medical condition that doubles mortality risk and increases risk of stroke by five-fold. Accordingly, such patients often need ambulatory monitoring to detect AF recurrences. Currently available AF monitoring devices have significant limitations, such as relatively few monitoring leads and the need to wear a device with attached wires and skin electrodes. CardioBip addresses these limitations as it does not employ any skin electrodes or wires. The handheld device conveniently records and wirelessly transmits information sufficient to reconstruct a full 12-lead ECG.

Vincent Renz, CEO of NewCardio, commented, "We are delighted to be presenting our latest CardioBip clinical study at the HRS Annual Scientific Meeting, a prestigious forum that is well-attended by cardiologists and electrophysiologists with a particular interest in novel solutions for long-term ambulatory cardiac monitoring. The exciting data from this study provide additional and very solid supporting evide




Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.